Surveillance report of bacterial resistance from hospitals in Shanghai in 2009

Chinese Journal of Infection and Chemotherapy

Volumn 10, Issue 6, 2010, Pages 403-413

  Zhu, Demei ^a   Zhang, Ying Yuan ^a   Wang, Fu ^a   Guo, Yan ^a   Jiang, Xiao Fei ^a   Ni, Yuxing ^a   Sun, Jingyong ^a   Ying, Chunmei ^a   Wang, Yaping ^a   Wang, Chuanqing ^a   Wang, Aimin ^a   Jiang, Yanqun ^a   Tang, Jing ^a   Zhang, Hong ^a   Li, Wanhua ^a   Shen, Yanya ^a   Jin, Wenmin ^a   Zhou, Tingyin ^a   Chen, Xianfeng ^a   Zhang, Bei ^a   Huang, Weichun ^a   Yang, Haihui ^a   Wei, Yingjue ^a   Tang, Rang ^a   Ding, Xing ^a   Wu, Ligui ^a   Wu, Nan ^a   Wang, Ruizhong ^a   Fang, Hua ^a   Lu, Xinhua ^a   Zhu, Aiying ^a   more..

^a FUDAN UNIVERSITY   (China)

Author keywords

Antimicrobial agent; Bacterial resistance; Bacterial susceptibility testing; Pan resistant organism

Indexed keywords

COAGULASE; IMIPENEM; LINEZOLID; MEROPENEM; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHINA; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE SURVEILLANCE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HOSPITAL; INFECTION CONTROL; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; PROTEUS MIRABILIS; STREPTOCOCCUS PNEUMONIAE;

EID: 78649909581     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. World Health Organization WHO global strategy for containment of antimicrobial resistance WHO/CDS/2001. 2.
2. Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Fifteenth Informational Supplement , 2009, M100-S19.
3. Sakoulas G, Moellering RC Jr. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains[J]. Clin Infect Dis,2008,46(S5):S360-S367.
4. Ball JM, Walters LJ, Turnidge D, et al. hVISA are commom among vacomycin-susceptible methicillin-resistant Staphylococcus aureus (MRSA) :report from SENTRY Asia-Pacific region [abstract C2-1160][C]//Program and abstracts of 46th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington ,DC i American Society for Microbiology, 2006.
5. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia [J]. Clin Infect Dis, 2008, 46(2),193-200.
6. Sun W, Chen H, Liu Y,et al, Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China? [J]. Antimicrob Agents Chemother, 2009, 53(9), 3642-3649.
7. Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Eighth Informational Supplement, 1998, M100-S8.
8. Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Sixteenth Informational Supplement ,2006, M100-S16.
9. Lahey Clinic. Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor-resistant β-lactamases [EB/OL], URL, http,//www.lahey.org/ studies/webt.asp.
10. Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing[S], Twentieth Informational Supplement, 2010, M100-S20.
11. Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [S]. Twentieth Informational Supplement(June 2010 Update) ,2010.M100-S20-U.